0001209191-23-010921.txt : 20230217
0001209191-23-010921.hdr.sgml : 20230217
20230217192347
ACCESSION NUMBER: 0001209191-23-010921
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230215
FILED AS OF DATE: 20230217
DATE AS OF CHANGE: 20230217
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Holmlin R. Erik
CENTRAL INDEX KEY: 0001579988
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38613
FILM NUMBER: 23644754
MAIL ADDRESS:
STREET 1: 4088 COMMERCIAL AVE.
CITY: NORTHBROOK
STATE: IL
ZIP: 60062
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Bionano Genomics, Inc.
CENTRAL INDEX KEY: 0001411690
STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826]
IRS NUMBER: 261756290
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9540 TOWNE CENTRE DRIVE
STREET 2: SUITE 100
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: (858) 888-7600
MAIL ADDRESS:
STREET 1: 9540 TOWNE CENTRE DRIVE
STREET 2: SUITE 100
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
FORMER COMPANY:
FORMER CONFORMED NAME: Bionano Genomics, Inc
DATE OF NAME CHANGE: 20190308
FORMER COMPANY:
FORMER CONFORMED NAME: BioNano Genomics, Inc
DATE OF NAME CHANGE: 20120703
FORMER COMPANY:
FORMER CONFORMED NAME: BioNanomatrix Inc
DATE OF NAME CHANGE: 20070906
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2023-02-15
0
0001411690
Bionano Genomics, Inc.
BNGO
0001579988
Holmlin R. Erik
C/O BIONANO GENOMICS, INC.
9540 TOWNE CENTRE DRIVE, SUITE 100
SAN DIEGO
CA
92121
1
1
0
0
President and CEO
Common Stock
2023-02-15
4
A
0
300000
0.00
A
841615
D
Common Stock
5025
I
Robert Erik Holmlin Traditional IRA
Stock Option (Right to Buy)
1.63
2023-02-15
4
A
0
1400000
0.00
A
2033-02-14
Common Stock
1400000
1400000
D
Represents restricted stock unit award granted under the Issuer's 2018 Equity Incentive Plan.
Includes 1,443 shares acquired under the Issuer's 2018 Employee Stock Purchase Plan (the "ESPP") on June 10, 2022 and 1,616 shares acquired under the ESPP on December 10, 2022.
The shares subject to the option shall vest monthly over 48 months beginning on the one-month anniversary of February 15, 2023 (the "Grant Date") such that the option shall be fully vested and exercisable on the four-year anniversary of the Grant Date.
/s/ R. Erik Holmlin
2023-02-17